{
    "nct_id": "NCT04452292",
    "official_title": "A Pilot Feasibility Study of Next Generation Sequencing-Based Stratification of Front Line Treatment of HighGrade Neuroendocrine Carcinoma",
    "inclusion_criteria": "* Histologically confirmed high grade neuroendocrine carcinoma that is metastatic and/or not resectable\n* Adequate tissue available for genomic sequencing\n* ECOG status less than or equal to 2\n* Able to consent\n* Patient received up to two cycles of chemotherapy prior to enrollment\n* Adequate bone marrow function\n* Adequate hepatic function\n* Adequate renal function\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Small cell carcinoma\n* Psychiatric illness or social situations that limit compliance\n* Pregnant and nursing women\n* Patients who have completed more than two cycles of chemotherapy\n* Patients with resectable cancer or eligible for curative therapy\n* Patients with an actionable mutation for with guidelines recommend up-front therapy with targeted agents",
    "miscellaneous_criteria": ""
}